ScripsAmerica's PIMD International Receives DEA License to Distribute Class 2 Through 5 Pharmaceutical Formularies
April 22 2014 - 08:30AM
ScripsAmerica, Inc. (OTCBB:SCRC) today announced
that PIMD International, LLC has recently received a license to
receive, store and ship Schedule 2 through Schedule 5 formulary
pharmaceuticals in Florida and Pennsylvania.
PIMD International's new headquarters, located in Doral,
Florida, passed the inspection process necessary to receive the
licenses for products that are designated as Schedule 2,3,4 and 5
by the DEA. The Company expects PIMD's revenue to grow with the
addition of these new formularies and is in the process of
expanding its market reach by applying for licensing in additional
states.
PIMD International serves as a pharmaceutical wholesaler to
pharmacies, hospitals, and physician's offices in the US and
provides ScripsAmerica's customers with access to specific
medications for its end users. PIMD also sells medical supplies in
all healthcare settings and online at www.pimdintl.com.
"We are very excited to receive these pharmaceutical
dispersement licenses by the DEA as they expand PIMD's ability to
service independent pharmacies in new areas with additional
products. We expect these new licenses to generate rapid growth in
our prescription revenues and expect to experience growth on all
fronts in 2014 which includes sales from our medical supply website
as well," stated PIMD International's Founder, Vanessa Gonzalez,
PharmD.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information, visit
www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACT: 888-959-7095
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Feb 2024 to Mar 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Mar 2023 to Mar 2024